Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Eswarachary"'
Publikováno v:
Indian Journal of Pathology and Microbiology, Vol 55, Iss 4, Pp 574-577 (2012)
Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML) in which abnormal promyelocytes predominate. APL is rare in children (approximately 10% of childhood AML) and is characterized by a higher incidence of hyperleukocytosis,
Externí odkaz:
https://doaj.org/article/94962f65400a41abb5fcc1e765b0709e
Publikováno v:
RE
The importance of middleware in the success of IT and enterprise systems cannot be over emphasized. Digital Transformation is increasing this importance exponentially. Despite such importance, the topic of requirements engineering in middleware has l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b353ea60ab0febaf0246397a1a170b07
https://doi.org/10.1109/re48521.2020.00060
https://doi.org/10.1109/re48521.2020.00060
Autor:
Sheela Nampoorthiri, Francis X Kidangan, G. Ravi Kumar, C. Kiran, R. Chandran, Ratna Dua Puri, Mamatha Gowda, Eswarachary Venkataswamy, Riyaz Akhtar, Meenu Batra, Jayshree Ganapathi Subramanian, Shruti Lingaiah, Sridevi Hegde, Pallavi Mishra, Neerja Gupta, Madhulika Kabra, Anita Kaul, Ishwar Chander Verma, Chitra Andrew, V. L. Ramprasad, Rashmi Bagga, Priya Kadam, Tulika Tayal
Publikováno v:
The Journal of Obstetrics and Gynecology of India. 68:462-470
INTRODUCTION: Noninvasive prenatal testing (NIPT) has revolutionized prenatal screening for chromosomal aneuploidies in some countries. Its implementation has been sporadic in developing countries. Given the genetic variation of the people in differe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dbceeeb6b3694384e5e1f764208e211
https://doi.org/10.1007/s13224-017-1061-9
https://doi.org/10.1007/s13224-017-1061-9
Autor:
ESWARACHARY, VENKATASWAMY1, MOHAMMED, IMRAN GORUR2 dr.imrangm@gmail.com, JAYANNA, PRASHANTH K.3, PATILOKALY, GEETA V.2, NARGUND, ASHWINI R.2, DHONDALAY, GOPAL KRISHNA3, PRABHUDESAI, SHILPA2, SAHOO, RASHMITA1
Publikováno v:
Journal of Clinical & Diagnostic Research. Apr2017, Vol. 11 Issue 4, p1-5. 5p.
Autor:
Eswarachary, Prashanth K Jayanna, Shilpa Prabhudesai, Patilokaly Gv, Mohammed Ig, Gopal Krishna R. Dhondalay, Rashmita Sahoo, Ashwini R. Nargund
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 11, Iss 4, Pp EC01-EC05 (2017)
Introduction: The development of trastuzumab, a HER-2/ neu targeted monoclonal antibody resulted in significant improvements in clinical response and survival in HER-2/neu gene amplified group of patients. Thus, accurate assessment of HER-2/neu statu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c780b1948312061c144594c5c7d2a89
https://europepmc.org/articles/PMC5449786/
https://europepmc.org/articles/PMC5449786/
Autor:
Verma, Ishwar Chander, Puri, Ratna, Venkataswamy, Eswarachary, Tayal, Tulika, Nampoorthiri, Sheela, Andrew, Chitra, Kabra, Madhulika, Bagga, Rashmi, Gowda, Mamatha, Batra, Meenu, Hegde, Sridevi, Kaul, Anita, Gupta, Neerja, Mishra, Pallavi, Subramanian, Jayshree Ganapathi, Lingaiah, Shruti, Akhtar, Riyaz, Kidangan, Francis, Chandran, R., Kiran, C.
Publikováno v:
Journal of Obstetrics & Gynecology of India; Dec2018, Vol. 68 Issue 6, p462-470, 9p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Venkataswamy Eswarachary, Imran Gorur Mohammed, Prashanth K Jayanna, Geeta V PatilOkaly, Ashwini R Nargund, Gopal Krishna Dhondalay, Shilpa Prabhudesai, Rashmita Sahoo
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 11, Iss 4, Pp EC01-EC05 (2017)
Introduction: The development of trastuzumab, a HER-2/ neu targeted monoclonal antibody resulted in significant improvements in clinical response and survival in HER-2/neu gene amplified group of patients. Thus, accurate assessment of HER-2/neu s
Externí odkaz:
https://doaj.org/article/5aa47fb8308f447ebd74e0b262aac201